The Technical Analyst
Select Language :
Exicure Inc [XCUR]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Exicure Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Exicure Inc is listed at the  Exchange

-3.09% $0.599

America/New_York / 28 mar 2024 @ 14:46


FUNDAMENTALS
MarketCap: 5.18 mill
EPS: 1.770
P/E: 0.340
Earnings Date: Mar 27, 2024
SharesOutstanding: 8.65 mill
Avg Daily Volume: 0.488 mill
RATING 2024-03-28
B+
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Strong Buy
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
1/222/223/224/221/232/23
Revenuen/a
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0.340 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.06x
Company: PE 0.340 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.535 - 0.663

( +/- 10.69%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-16 Miller Josh Sell 46 Common Stock
2024-02-29 Dgp Co., Ltd. Sell 3 400 000 Common Stock
2023-11-16 Miller Josh Sell 38 Common Stock
2023-09-26 Eom Minhee Buy 0
2023-08-21 Ko Hyuk Joon Buy 0
INSIDER POWER
-60.68
Last 81 transactions
Buy: 16 542 799 | Sell: 13 981 621

Forecast: 16:00 - $0.599

Live Trading Signals (every 1 min)

Forecast 1: 14:55 - $0.585
Forecast 2: 15:45 - $0.589
Forecast 3: 16:00 - $0.599
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.599 (-3.09% )
Volume 0.0287 mill
Avg. Vol. 0.488 mill
% of Avg. Vol 5.87 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Exicure Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Exicure Inc

RSI

Last 10 Buy & Sell Signals For XCUR

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Exicure Inc

XCUR

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Last 10 Buy Signals

Date Signal @
HNTUSDMar 28 - 15:08$6.13
NTRSMar 28 - 15:05$88.62
DLTRMar 28 - 15:05$133.24
FSLRMar 28 - 15:04$168.29
FWONKMar 28 - 15:04$66.20
ACLSMar 28 - 15:02$111.89
SQQQMar 28 - 14:57$10.41
FTNUSDMar 28 - 14:561.810
^NYAMar 28 - 14:42PTS18 301
^SPXMar 28 - 14:425 250.40

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.